Cinacalcet
Cinacalcet is a prescription medication that acts as a calcium-sensing receptor agonist, helping to lower parathyroid hormone levels in patients with chronic kidney disease on dialysis or certain parathyroid conditions. Available as oral tablets in 30mg, 60mg, and 90mg strengths, it's manufactured by Dr. Reddy's Laboratories Inc. under ANDA208368. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Cinacalcet is a prescription medication that acts as a calcium-sensing receptor agonist, helping to lower parathyroid hormone levels in patients with chronic kidney disease on dialysis or certain parathyroid conditions. Available as oral tablets in 30mg, 60mg, and 90mg strengths, it's manufactured by Dr. Reddy's Laboratories Inc. under ANDA208368. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Cinacalcet",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Cinacalcet — ANDA 204364 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204364"
}
]
|
| identifier | ANDA204364 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Cinacalcet |
